Gemcitabine plus S-1 versus cetuximab as a third-line therapy in metastatic colorectal cancer: an observational trial. [electronic resource]

By: Contributor(s): Producer: 20160217Description: 21159-65 p. digitalISSN:
  • 1940-5901
 In: International journal of clinical and experimental medicine vol. 8
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.